Form 4 for LEXX Lexaria Bioscience Corp.
Accepted 2022-05-19 00:00:00 ET · period of report 2022-05-18 · accession 0001855763-22-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-05-19 | 2022-05-18+ | LEXX | REESE ALBERT L JR | Dir | A - Grant | $2.01 | +3,201 | 2,617 | New | +$6,434 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | common shares | 2022-05-19 | A | A | 1,501 | $2.01 | 4,118 | D | — | — | |
| 2 | Common | common shares | 2022-05-18 | A | A | 1,700 | $2.01 | 2,617 | D | — | — |